Literature DB >> 9065782

Functional interaction of the carboxylic acid group of agonists and the arginine residue of the seventh transmembrane domain of prostaglandin E receptor EP3 subtype.

C Chang1, M Negishi, N Nishigaki, A Ichikawa.   

Abstract

Prostaglandin (PG) E2 binds to PGE receptor EP3 subtype and induces Gi activity. To assess the role of the interaction of the carboxylic acid group of agonists and its putative binding site, Arg-309 in the seventh transmembrane domain of EP3alpha receptor, in receptor activation, we have mutated the positively charged Arg-309 to the polar but uncharged Gln (EP3alpha-R309Q) and Asn (EP3alpha-R309N), and to the non-polar Leu (EP3alpha-R309L). Wild-type, EP3alpha-R309Q and EP3alpha-R309N receptors showed high-affinity binding for PGE2, but the EP3alpha-R309L receptor showed very-low-affinity binding. Guanosine 5'-[gamma-thio]triphosphate increased the PGE2 binding to the wild-type receptor, decreased the binding to EP3alpha-R309Q and EP3alpha-R309N receptors, but did not affect that to the EP3alpha-R309L receptor. Furthermore we examined the Gi activities of two types of EP3 agonist, TEI-3356 with a negatively charged carboxylic acid, and TEI-4343, a methyl ester of TEI-3356 with an uncharged but polar group, towards those receptors. Both agonists inhibited the forskolin-stimulated cAMP formation in wild-type, EP3alpha-R309Q and EP3alpha-R309N receptors in the same concentration-dependent manner, but the agonists showed a very low inhibition of EP3alpha-R309L receptor. These findings demonstrate that the hydrogen-bonding interaction of EP3 agonists and residue 309 in the seventh transmembrane domain of the EP3alpha receptor is sufficient for the functional activation of the EP3alpha receptor.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9065782      PMCID: PMC1218231          DOI: 10.1042/bj3220597

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  22 in total

1.  Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure.

Authors:  P L Felgner; T R Gadek; M Holm; R Roman; H W Chan; M Wenz; J P Northrop; G M Ringold; M Danielsen
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

2.  Apical-basolateral membrane asymmetry in canine cortical collecting tubule cells. Bradykinin, arginine vasopressin, prostaglandin E2 interrelationships.

Authors:  A Garcia-Perez; W L Smith
Journal:  J Clin Invest       Date:  1984-07       Impact factor: 14.808

3.  Covalent cross-linking of prostaglandin E receptor from bovine adrenal medulla with a pertussis toxin-insensitive guanine nucleotide-binding protein.

Authors:  M Negishi; S Ito; T Tanaka; H Yokohama; H Hayashi; T Katada; M Ui; O Hayaishi
Journal:  J Biol Chem       Date:  1987-09-05       Impact factor: 5.157

4.  Interaction of prostaglandin E2 and beta-adrenergic catecholamines in the regulation of uterine smooth muscle motility and adenylate cyclase in the rat.

Authors:  J F Krall; J D Barrett; N Jamgotchian; S G Korenman
Journal:  J Endocrinol       Date:  1984-09       Impact factor: 4.286

5.  TEI-3356, a highly selective agonist for the prostaglandin EP3 receptor.

Authors:  M Negishi; A Harazono; Y Sugimoto; A Hazato; S Kurozumi; A Ichikawa
Journal:  Prostaglandins       Date:  1994-11

6.  Prostanoid inhibition of canine parietal cells: mediation by the inhibitory guanosine triphosphate-binding protein of adenylate cyclase.

Authors:  M C Chen; D A Amirian; M Toomey; M J Sanders; A H Soll
Journal:  Gastroenterology       Date:  1988-05       Impact factor: 22.682

7.  Conserved aspartic acid residues 79 and 113 of the beta-adrenergic receptor have different roles in receptor function.

Authors:  C D Strader; I S Sigal; M R Candelore; E Rands; W S Hill; R A Dixon
Journal:  J Biol Chem       Date:  1988-07-25       Impact factor: 5.157

8.  Expression and site-directed mutagenesis of mouse prostaglandin E2 receptor EP3 subtype in insect cells.

Authors:  C Huang; H H Tai
Journal:  Biochem J       Date:  1995-04-15       Impact factor: 3.857

9.  Selective coupling of prostaglandin E receptor EP3D to multiple G proteins depending on interaction of the carboxylic acid of agonist and arginine residue of seventh transmembrane domain.

Authors:  M Negishi; A Harazono; Y Sugimoto; A Hazato; S Kurozumi; A Ichikawa
Journal:  Biochem Biophys Res Commun       Date:  1995-07-17       Impact factor: 3.575

Review 10.  Molecular mechanisms of diverse actions of prostanoid receptors.

Authors:  M Negishi; Y Sugimoto; A Ichikawa
Journal:  Biochim Biophys Acta       Date:  1995-10-26
View more
  3 in total

1.  Fitting the complexity of GPCRs modulation into simple hypotheses of ligand design.

Authors:  Chiara Custodi; Roberto Nuti; Tudor I Oprea; Antonio Macchiarulo
Journal:  J Mol Graph Model       Date:  2012-07-20       Impact factor: 2.518

2.  Identification by site-directed mutagenesis of amino acids contributing to ligand-binding specificity or signal transduction properties of the human FP prostanoid receptor.

Authors:  Frank Neuschäfer-Rube; Eva Engemaier; Sina Koch; Ulrike Böer; Gerhard P Püschel
Journal:  Biochem J       Date:  2003-04-15       Impact factor: 3.857

3.  New insights into human prostacyclin receptor structure and function through natural and synthetic mutations of transmembrane charged residues.

Authors:  J Stitham; E Arehart; S R Gleim; N Li; K Douville; J Hwa
Journal:  Br J Pharmacol       Date:  2007-08-20       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.